Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDAC Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03382834
What this trial is testing

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 31
Early research (Phase 1)Study completedNCT01567709
What this trial is testing

Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Ended earlyNCT00087477
What this trial is testing

A Pilot Study of Pivanex in Patients With Malignant Melanoma

Who this might be right for
Malignant Melanoma
Titan Pharmaceuticals 14
Testing effectiveness (Phase 2)Study completedNCT00798720
What this trial is testing

Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non Small Cell Lung
University of Wisconsin, Madison 18
Testing effectiveness (Phase 2)Study completedNCT00928707
What this trial is testing

Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera

Who this might be right for
Polycythemia Vera
Italfarmaco 45
Testing effectiveness (Phase 2)UnknownNCT02759601
What this trial is testing

Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Queen Mary University of London 69
Testing effectiveness (Phase 2)Study completedNCT00589290
What this trial is testing

Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage

Who this might be right for
ThymomaThymic Carcinoma
National Cancer Institute (NCI) 41
Not applicableUnknownNCT03515915
What this trial is testing

Use Lay Language. HA Score to Identify Myeloma Patients Who Could Benefit From HDACi Treatment

Who this might be right for
Patients With Recurrent or Refractory Multiple Myeloma
University Hospital, Montpellier 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03934567
What this trial is testing

A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Lymphoma, Follicular
Xynomic Pharmaceuticals, Inc. 87
Testing effectiveness (Phase 2)Active Not RecruitingNCT01038778
What this trial is testing

Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 47
Early research (Phase 1)Study completedNCT03187015
What this trial is testing

Examine the Effects of Entinostat on Midazolam in Healthy Adult Subjects

Who this might be right for
Drug InteractionHealthy Volunteer
Syndax Pharmaceuticals 26
Testing effectiveness (Phase 2)Study completedNCT01111526
What this trial is testing

Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD)

Who this might be right for
Graft-Versus-Host Disease
H. Lee Moffitt Cancer Center and Research Institute 22
Testing effectiveness (Phase 2)Study completedNCT03770000
What this trial is testing

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

Who this might be right for
T Cell Lymphoma
Rhizen Pharmaceuticals SA 33
Testing effectiveness (Phase 2)Ended earlyNCT01090830
What this trial is testing

Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
Holy Cross Hospital, Florida 7
Early research (Phase 1)Not Yet RecruitingNCT07635992
What this trial is testing

A Clinical Study Evaluating the Safety, Tolerability, and Effect on HIV Reservoir of Ibalizumab Combined With Chidamide (a Histone Deacetylase Inhibitor) in People Living With HIV

Who this might be right for
HIV (Human Immunodeficiency Virus)
First Affiliated Hospital of Zhejiang University 18
Early research (Phase 1)Study completedNCT00503451
What this trial is testing

Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors

Who this might be right for
Non-Hodgkin LymphomaNeoplasms
Novartis Pharmaceuticals 14
Testing effectiveness (Phase 2)Looking for participantsNCT03167437
What this trial is testing

An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab

Who this might be right for
Crohn's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 35
Early research (Phase 1)Ended earlyNCT01116154
What this trial is testing

Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+28 more
City of Hope Medical Center 30
Early research (Phase 1)Study completedNCT00820508
What this trial is testing

Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies

Who this might be right for
Hematological DiseaseLymphoid Malignancies
Chroma Therapeutics 18
Testing effectiveness (Phase 2)Study completedNCT00773838
What this trial is testing

Study of Vorinostat (MK0683), an Histone Deacetylase (HDAC) Inhibitor in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (MK-0683-095)

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Merck Sharp & Dohme LLC 143
Next Page